PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1.

[1]  John C Gore,et al.  Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer , 2008, Clinical Cancer Research.

[2]  C. Sheridan.  EGFR inhibitors embrace KRAS , 2008, Nature Biotechnology.

[3]  Sanjay Goel,et al.  PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab. , 2008, Cancer research.

[4]  A. Paller,et al.  Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. , 2007, Cancer research.

[5]  E. Rozengurt,et al.  Protein kinase Calpha mediates feedback inhibition of EGF receptor transactivation induced by Gq-coupled receptor agonists. , 2007, Cellular signalling.

[6]  J. Black,et al.  Protein Kinase C-mediated Down-regulation of Cyclin D1 Involves Activation of the Translational Repressor 4E-BP1 via a Phosphoinositide 3-Kinase/Akt-independent, Protein Phosphatase 2A-dependent Mechanism in Intestinal Epithelial Cells* , 2007, Journal of Biological Chemistry.

[7]  M. Leitges,et al.  Protein kinase c alpha but not PKC zeta suppresses intestinal tumor formation in Apc(Min/+) mice , 2006 .

[8]  J. Black,et al.  Protein Kinase C α Signaling Inhibits Cyclin D1 Translation in Intestinal Epithelial Cells* , 2006, Journal of Biological Chemistry.

[9]  P. Majumder,et al.  Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators , 2006, Oncogene.

[10]  D. Goldstein,et al.  Interferon-α Promotes the Anti-Proliferative Effect of Gefitinib (ZD1839) on Human Colon Cancer Cell Lines , 2005, Oncology.

[11]  H. Clevers,et al.  Cyclin D1 Is Not an Immediate Target of β-Catenin following Apc Loss in the Intestine* , 2005, Journal of Biological Chemistry.

[12]  D. Powell,et al.  The role of protein kinase C in gastrointestinal function and disease. , 2005, Gastroenterology.

[13]  Shufeng Zhou,et al.  The PKCalpha-D294G mutant found in pituitary and thyroid tumors fails to transduce extracellular signals. , 2005, Cancer research.

[14]  Chenguang Wang,et al.  Minireview: Cyclin D1: normal and abnormal functions. , 2004, Endocrinology.

[15]  L. Augenlicht,et al.  Cyclin D1 Genetic Heterozygosity Regulates Colonic Epithelial Cell Differentiation and Tumor Number in ApcMin Mice , 2004, Molecular and Cellular Biology.

[16]  D. Tan,et al.  Intestinal Tumor Progression Is Associated with Altered Function of KLF5* , 2004, Journal of Biological Chemistry.

[17]  A. Quinn,et al.  Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma. , 2003, Cancer research.

[18]  M. Denning,et al.  Activation of Protein Kinase C Triggers Irreversible Cell CycleWithdrawal In Human Keratinocytes , 2002 .

[19]  Thierry Soussi,et al.  Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. , 2002, Gastroenterology.

[20]  Kan Yang,et al.  Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 , 2002, Science.

[21]  J. Diehl.  Cycling to Cancer with Cyclin D1 , 2002, Cancer biology & therapy.

[22]  Victor E. Marquez,et al.  Diacylglycerol (DAG)-lactones, a New Class of Protein Kinase C (PKC) Agonists, Induce Apoptosis in LNCaP Prostate Cancer Cells by Selective Activation of PKCα* , 2002, The Journal of Biological Chemistry.

[23]  J. Hsuan,et al.  EGF receptors as transcription factors: ridiculous or sublime? , 2001, Nature Cell Biology.

[24]  J. Black.  Protein kinase C isozymes in colon carcinogenesis: guilt by omission. , 2001, Gastroenterology.

[25]  A. Fields,et al.  Elevated protein kinase C betaII is an early promotive event in colon carcinogenesis. , 2001, Cancer research.

[26]  Jennifer A. Clark,et al.  Protein Kinase C Signaling Mediates a Program of Cell Cycle Withdrawal in the Intestinal Epithelium , 2000, The Journal of cell biology.

[27]  T. Sugimura,et al.  Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. , 2000, Carcinogenesis.

[28]  I. Weinstein.  Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. , 2000, Carcinogenesis.

[29]  W. Karnes,et al.  Adenoma-specific alterations of protein kinase C isozyme expression in Apc(MIN) mice. , 2000, Cancer research.

[30]  J. Black.  Protein kinase C-mediated regulation of the cell cycle. , 2000, Frontiers in bioscience : a journal and virtual library.

[31]  Zhimin Lu,et al.  Antagonistic Effects of Protein Kinase C α and δ on Both Transformation and Phospholipase D Activity Mediated by the Epidermal Growth Factor Receptor , 1999, Molecular and Cellular Biology.

[32]  H. Esumi,et al.  Expression of the cyclin D1 gene in rat colorectal aberrant crypt foci and tumors induced by azoxymethane. , 1999, Cancer letters.

[33]  N. Petrelli,et al.  Colonocyte differentiation is associated with increased expression and altered distribution of protein kinase C isozymes. , 1998, Gastroenterology.

[34]  A. G. de Herreros,et al.  Protein Kinase C-α Activity Inversely Modulates Invasion and Growth of Intestinal Cells* , 1998, The Journal of Biological Chemistry.

[35]  Y. Hosokawa,et al.  Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele‐specific expression , 1998, Genes, chromosomes & cancer.

[36]  C. Abraham,et al.  Decreased PKC-α Expression Increases Cellular Proliferation, Decreases Differentiation, and Enhances the Transformed Phenotype of CaCo-2 Cells , 1998 .

[37]  C. Abraham,et al.  Protein kinase C α modulates growth and differentiation in Caco-2 cells , 1998 .

[38]  L. Zon,et al.  Induction of cyclin D1 by simian virus 40 small tumor antigen. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Bissonnette,et al.  Protein kinase C isoforms in the chemopreventive effects of a novel vitamin D3 analogue in rat colonic tumorigenesis. , 1996, Gastroenterology.

[40]  J. Lord,et al.  Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids , 1995, International journal of cancer.

[41]  R Fodde,et al.  A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Black,et al.  Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ , 1994, The Journal of cell biology.

[43]  B. Marian,et al.  Five of six protein kinase C isoenzymes present in normal mucosa show reduced protein levels during tumor development in the human colon. , 1994, Carcinogenesis.

[44]  P. Dudeja,et al.  Down-regulation of protein kinase C activity in 1,2-dimethylhydrazine-induced rat colonic tumors. , 1991, Biochimica et biophysica acta.

[45]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[46]  H. Pitot,et al.  A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. , 1990, Science.

[47]  M. Rousset,et al.  The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. , 1986, Biochimie.

[48]  M. Leitges,et al.  Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice. , 2006, Cancer research.

[49]  J. Black,et al.  Protein kinase C alpha signaling inhibits cyclin D1 translation in intestinal epithelial cells. , 2006, The Journal of biological chemistry.

[50]  D. Goldstein,et al.  Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell lines. , 2005, Oncology.

[51]  L. Carpenter,et al.  PKCα Is Activated But Not Required During Glucose-Induced Insulin Secretion From Rat Pancreatic Islets , 2004 .

[52]  J. Willson,et al.  Heterogeneity of human colon carcinoma , 2004, Cancer and Metastasis Reviews.

[53]  L. Carpenter,et al.  PKC alpha is activated but not required during glucose-induced insulin secretion from rat pancreatic islets. , 2004, Diabetes.

[54]  M. Denning,et al.  Activation of protein kinase C triggers irreversible cell cycle withdrawal in human keratinocytes. , 2002, The Journal of investigative dermatology.

[55]  A. Hornia,et al.  Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor. , 1999, Molecular and cellular biology.

[56]  C. Abraham,et al.  Protein kinase C alpha modulates growth and differentiation in Caco-2 cells. , 1998, Gastroenterology.

[57]  C. Abraham,et al.  Decreased PKC-alpha expression increases cellular proliferation, decreases differentiation, and enhances the transformed phenotype of CaCo-2 cells. , 1998, Cancer research.

[58]  J. Black,et al.  Protein Kinase C Isozyme-mediated Cell Cycle Arrest Involves Induction of p21 waf1/cip1 and p27 kip1 and Hypophosphorylation of the Retinoblastoma Protein in Intestinal Epithelial Cells* , 1997 .

[59]  K. Berkner.  Expression of heterologous sequences in adenoviral vectors. , 1992, Current topics in microbiology and immunology.